Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.

Tests for human herpesvirus-8 (HHV-8) often disagree on which individuals are infected. To evaluate HHV-8 antibody changes over many years, 245 homosexual men enrolled in a prospective study between 1982 and 1999 were studied. Samples collected annually were evaluated by immunofluorescence to HHV-8 latent nuclear antigen and by an ELISA for antibody against the HHV-8 lytic antigen K8.1. When positive, samples from most subjects were persistently reactive in both assays. Titers to both lytic and latent antibodies increased for many years, usually in parallel, and were higher in human immunodeficiency virus-infected men. The increasing titers and expanding epitope recognition suggest ongoing, low-grade replication of HHV-8. Use of multiple assays is important in determining prevalence in asymptomatic populations. Because persons with more advanced infections have higher antibody titers, they are easier to detect, which may skew our understanding of the epidemiology of HHV-8.

[1]  F. Goebel,et al.  Kaposi's sarcoma‐associated herpesvirus serology in Europe and Uuganda: Multicentre study with multiple and novel assays , 2001, Journal of medical virology.

[2]  C. Boshoff,et al.  Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain , 2001, AIDS.

[3]  P. Vernazza,et al.  Longitudinal sero‐reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS , 2001, Journal of medical virology.

[4]  A. Wald,et al.  Mucosal shedding of human herpesvirus 8 in men. , 2000, The New England journal of medicine.

[5]  J. Phair,et al.  Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. , 2000, The Journal of infectious diseases.

[6]  S. Heisterkamp,et al.  Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Goedert,et al.  Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. , 2000 .

[8]  J. Goedert,et al.  Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. , 1999, The Journal of infectious diseases.

[9]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[10]  T. Schulz,et al.  Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma , 1998, AIDS.

[11]  K. Begtrup,et al.  Risk factors for Kaposi's‐sarcoma‐associated herpesvirus (KSHV/HHV‐8) seropositivity in a cohort of homosexual men, 1981–1996 , 1998, International journal of cancer.

[12]  R. Biggar,et al.  Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. , 1998, The Journal of infectious diseases.

[13]  H. Whittle,et al.  Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. , 1998, Journal of human virology.

[14]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus. , 1997, Advances in cancer research.

[15]  F. Vitale,et al.  Human herpesvirus type 8 DNA sequences in biological samples of HIV‐positive and negative individuals in Sicily , 1997, AIDS.

[16]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[17]  J. Levy,et al.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients , 1996, The Lancet.

[18]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[19]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[20]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[21]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[22]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[23]  J. Goedert,et al.  Decreased helper T lymphocytes in homosexual men. II. Sexual practices. , 1985, American journal of epidemiology.

[24]  J. Goedert,et al.  DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MEN , 1984, The Lancet.

[25]  R. Biggar,et al.  Humoral immune response to epstein‐barr virus antigens and immunoglobulin allotypes in African burkitt lymphoma patients , 1984, International journal of cancer.